[Iatrogenic ergotism. Apropos of a case]. | Canada Hyperbarics Skip to main content
Clinical Study Toxicological European research. Recherche europeenne en toxicologie 1978

[Iatrogenic ergotism. Apropos of a case].

Le Bricquir M, Droy JM, Leroy J, Fillastre JP — Toxicological European research. Recherche europeenne en toxicologie, 1978

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers presented a case of iatrogenic ergotism in a 36-year-old woman and reviewed 63 similar cases from the literature.

What They Found

A 36-year-old woman developed generalized arterial spasm and feet necrosis, requiring transmetatarsal amputation, after receiving Ergotamine Tartrate 4.5 mg daily for seven days post-abortion. This case, along with 63 others reviewed in the literature, demonstrated the potential for severe iatrogenic ergotism, including arteriolar thrombosis and tissue gangrene, even at normally accepted therapeutic doses.

What This Means for Canadian Patients

Canadian patients prescribed ergot derivatives, such as ergotamine tartrate, should be aware of the potential for severe side effects like arterial spasm and tissue damage, even at standard doses. Early recognition of symptoms and prompt medical intervention, potentially involving heparin, dextran, or sodium nitroprussiate, is crucial to mitigate severe outcomes.

Canadian Relevance

This study has no direct Canadian connection as it is a case report and literature review from 1978 without Canadian authors or study sites.

Study Limitations

As a case report supplemented by a literature review, this study lacks the statistical power and controlled design of a randomized clinical trial.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Infection
Source Pubmed
PubMed ID 741476
Year Published 1978
Journal Toxicological European research. Recherche europeenne en toxicologie
MeSH Terms Adult; Amputation, Surgical; Ergotamines; Ergotism; Female; Gangrene; Humans; Necrosis

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.